Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Kalvista Pharmaceuticals Inc (KALV) announced that it will release its financial results for the first eight months of fiscal year 2025 on March 25, 2026, and will also provide an update on the latest developments in the company's business.

Kalvista Pharmaceuticals Inc (KALV) announced that it will release its financial results for the first eight months of fiscal year 2025 on March 25, 2026, and will also provide an update on the latest developments in the company's business.

老虎证券老虎证券2026/03/18 11:26
Show original
This biopharmaceutical company, which specializes in developing oral plasma kallikrein inhibitors, has adjusted its financial reporting period to eight months in this earnings report, sparking speculation in the market about the reasons behind the change in its financial disclosure approach. Analysts are generally focused on the latest clinical progress and regulatory timeline of its core candidate drug sebetralstat (KVD824) for the acute treatment of hereditary angioedema (HAE). According to industry practice, the focus of biotech company earnings reports often goes beyond traditional financial metrics, placing greater emphasis on pipeline milestones, interpretation of clinical data, and cash flow status. Kalvista is currently at a critical clinical stage, and the ratio of its cash reserves to R&D expenditure will directly affect investors’ assessment of its R&D sustainability. After the earnings release, management will hold a conference call at 8:30 AM Eastern Time, during which they are expected to provide a detailed interpretation of clinical trial progress, communications with regulatory agencies, and R&D strategic planning for the next twelve months.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Morningstar expects Woodside's revenue growth will outpace global peers by the end of this decade

On October 9, Morningstar predicted that the revenue of Australian oil and gas producer Woodside Energy (WDS.AX) will grow by over 30% by 2030, outpacing any of its international peers. Woodside Energy’s share price dropped by 0.6% on the day to 32.12 AUD, after surging 2.6% in the previous trading session. The stock is poised to end a three-week losing streak, with oil prices rising due to escalating tensions in the Middle East, and is set for a 2.8% weekly gain O/R. Morningstar expects Woodside’s revenue to increase as major new projects come online, and forecasts free cash flow to exceed 7 billion USD after 2030, reflecting a 300% rise from 2025. The report added that market sentiment remains bearish, with the current share price below its estimated fair value of 44.00 AUD. Year-to-date, Woodside’s share price has risen 36.2%, while Santos shares are up 41.3%. (For the convenience of non-English speakers, Reuters has automated the translation of its reports into several languages. Since automated translations may be inaccurate or lack required context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for the convenience of readers. Reuters accepts no liability for any loss or damage arising from your use of automated translation functions.)

路透社•2026/10/09 02:16

Star analyst Ives: Bullish on Apple (AAPL.US) up to $400, AI strategy may increase valuation by $75 per share

Ives has given Apple stock an "outperform" rating, with a target price of $400.

智通财经•2026/10/09 02:01

New York gold prices rose on the 8th

新浪财经•2026/10/09 01:36

BUZZ - After the turmoil of Firmus' initial public offering, Australia's Maas Group shares plunged nearly 30% this week

October 9 - ** Shares of Australian Maas Group (MGH.AX) have fallen more than 27% so far this week and are set for their worst weekly performance if the downward trend continues. ** On Thursday, media reported that Firmus, backed by Nvidia, might reduce the size of its AUD 5 billion Australian IPO (link), sparking investor concerns and leading to a 30% plunge in shares of construction services provider MGH. ** MGH holds a 3.2% stake in this AI data center operator. ** MGH suspended trading on Friday (link), pending an announcement related to Firmus. Firmus has shelved its AUD 5 billion listing plan due to market volatility and conditions. ** Before the suspension, MGH's shares had already fallen over 8% this year. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. This automated translation may contain inaccuracies or omit the desired context; Reuters does not guarantee the accuracy of automated translations and provides them solely for reader convenience. Reuters accepts no liability for any harm or loss caused by the use of automated translations.)

路透社•2026/10/09 01:26